SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0001104659-11-007895
Filing Date
2011-02-17
Accepted
2011-02-17 06:05:17
Documents
4
Group Members
ALCON, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13E-3 a11-4997_1sc13e3a.htm SC 13E3/A 148910
2 VON DER CRONE LEGAL OPINION a11-4997_1ex99dc12.htm EX-99.(C)(12) 217041
3 NOBEL & HUG LEGAL OPINION a11-4997_1ex99dc13.htm EX-99.(C)(13) 329537
4 GRAPHIC g49971mr05i001.jpg GRAPHIC 2925
  Complete submission text file 0001104659-11-007895.txt   701560
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13E3/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address BOSCH 69 6331 HUNENBERG SWITZERLAND V8 0000
Business Address 6201 SOUTH FREEWAY FORT WORTH TX 76134 8175686248
ALCON INC (Subject) CIK: 0001167379 (see all company filings)

IRS No.: 980205094 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-78796 | Film No.: 11619206
SIC: 3851 Ophthalmic Goods